Clinical Trial Update: A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a clinical and molecular risk-directed therapy for newly diagnosed medulloblastoma; status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Medulloblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING